AbbVie: Does Express Hep-C Deal Presage Other Such Discounts? Asks Credit ... Barron's (blog) Credit Suisse's Vamil Divan today reiterates an Outperform rating on shares of AbbVie (ABBV) after yesterday's news the company secured a deal with Express Scripts (ESRX) to be the sole hepatitis-C cure carried by the pharmacy management chain. |
Best Bloggains (Bargains and Blogs to Help Make a Better World) Save money with a little advice along the way trying to help get society back on track
Tuesday, December 23, 2014
AbbVie: Does Express Hep-C Deal Presage Other Such Discounts? Asks Credit ... - Barron's (blog)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment